Company intelligence / Profile preview

Perfect Balance Bio

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Perfect Balance Bio is an early-stage biotechnology company focused on developing next-generation metabolic therapies for obesity and related disorders. The company leverages expertise in incretin biology to design small molecule oral therapeutics aimed at providing more accessible and tolerable alternatives to current injectable treatments. Founded by leaders in the metabolic space, the company's research focuses on optimizing GLP-1 and GIP receptor agonism through innovative chemical structures. Perfect Balance Bio is currently in the pre-clinical stage, refining its lead candidates for future human trials.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Perfect Balance Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perfect Balance Bio.

Explore the full profile